THC and CBD Produce Largely Non-Overlapping Molecular Effects Across Species and Tissues | Research

The takeaway

A systematic comparison of 105 datasets found CBD and THC have distinct molecular signatures, with CBD showing more consistent anti-inflammatory and metabolic effects while THC primarily affected neuronal signaling.

Researchers studying cannabinoid mechanisms and anyone interested in the biological differences between THC and CBD.

THC and CBD showed largely non-overlapping transcriptomic signatures across 105 datasets

What the researchers found

CBD datasets showed more differentially expressed genes and enriched pathways across species. CBD effects clustered by administration route and species and were enriched for inflammation suppression, zinc homeostasis, and cell cycle regulation. THC signatures were more variable but consistently affected antioxidant activity, neuronal myelination, and synaptic signaling. THC altered endocannabinoid genes mainly in brain tissue, while CBD affected them in both central and peripheral tissues.

Why it matters

Despite being the two main cannabinoids, THC and CBD are often discussed interchangeably. This comprehensive molecular comparison shows they affect fundamentally different biological pathways, supporting the need to consider them as distinct therapeutic agents.

The numbers in context

105 datasets analyzed across 4 mammalian species. CBD showed more differentially expressed genes overall. CBD DEGs associated with lipid metabolism and body composition. Both compounds linked to neuropsychiatric disorders and type 2 diabetes. THC altered endocannabinoid signaling mainly in brain; CBD affected both central and peripheral tissues.

How the study worked

Curation and analysis of 105 THC and CBD RNA-sequencing and microarray datasets from NCBI GEO across mammalian species (human, rhesus macaque, mouse, rat). Meta-analysis identified common gene signatures, with pathway enrichment, network analysis, and disease association analysis.

What this study cannot tell us

Analysis of existing datasets introduces heterogeneity in experimental conditions. Different doses, exposure durations, and tissue types across studies. Transcriptomic changes do not always translate to functional outcomes. Publication bias toward certain tissues and species.

How to read the evidence

Moderate: comprehensive meta-analysis of many datasets with rigorous bioinformatics, but limited by heterogeneity of source data and lack of functional validation.

When this study was published

2025 study.

The bigger picture

This is one of the most comprehensive molecular comparisons of THC and CBD to date. The finding that their effects are largely non-overlapping has implications for product formulation, clinical trials, and understanding why different cannabis products produce different effects.

Questions still open

How do THC and CBD interact molecularly when administered together? Do the distinct pathways explain why different CBD:THC ratios produce different clinical effects? Are there optimal tissue targets for each cannabinoid?

Common questions

Are THC and CBD really that different molecularly?

Yes. This study found their gene expression effects were largely non-overlapping, with CBD consistently affecting inflammation and metabolism pathways while THC primarily affected neuronal signaling.

Which cannabinoid had more consistent effects?

CBD showed more consistent and reproducible molecular effects across datasets, species, and tissues. THC effects were more heterogeneous and context-dependent.

Read the original research

Comparative analysis of 105 datasets across species and tissues reveals differential transcriptomic responses to cannabinoids THC and CBD.

Journal of cannabis research, 8(1), 13

View on PubMed ↗Publisher’s paper ↗

Citation

Liu, Ruoshui; Kowal, Thomas; Chow, Caden; Olson, Tyler; Nguyen, Emily; Yang, Sen; Lee, Jimin; Cai, Hua; Yang, Xia; Blencowe, Montgomery. (2025). Comparative analysis of 105 datasets across species and tissues reveals differential transcriptomic responses to cannabinoids THC and CBD.. Journal of cannabis research, 8(1), 13. https://doi.org/10.1186/s42238-025-00361-0